[Federal Register Volume 90, Number 50 (Monday, March 17, 2025)]
[Notices]
[Page 12329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-04241]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications/contract proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications/contract 
proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA REI: Research at Minority Serving Institutions 
on Neurocognitive Mechanisms Underlying the Impact of Structural 
Racism on the Substance Use Trajectory.
    Date: April 3, 2025.
    Time: 11:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institute of Health, National Institute on 
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Shareen A. Iqbal, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, 
MSC 6021, Bethesda, MD 20892, (301) 443-4577, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; SBIR Phase II Topic 167: Cause of Death Elucidated 
(CODE) in Drug Overdose: Research and Development of New Postmortem 
Toxicology Screening Devices that are Portable, Rapid, Accurate, 
Affordable, and Accessible.
    Date: April 10, 2025.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Address: National Institute of Health, National Institute on 
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Trinh T. Tran, Ph.D., Scientific Review Officer, 
Scientific Review Branch, Office of Extramural Policy, National 
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC 
6021, Bethesda, MD 20892, (301) 827-5843, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Member Conflict: Medications and Devices for 
Treatment of SUD.
    Date: May 12, 2025.
    Time: 2:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institute of Health, National Institute on 
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Sudhirkumar U. Yanpallewar, M.D., Scientific 
Review Officer, Scientific Review Branch, National Institute on Drug 
Abuse, NIH, 301 North Stonestreet Avenue, MSC 6021, Bethesda, MD 
20892, (301) 443-4577, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: March 11, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2025-04241 Filed 3-14-25; 8:45 am]
BILLING CODE 4140-01-P